Transgenic studies of pain

Pain

Volumn 77, Issue 2, 1998, Pages 107-128

  Mogil, Jeffrey S ^a   Grisel, Judith E ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b FURMAN UNIVERSITY   (United States)

Author keywords

Analgesic sensitivity; Knockout mice; Nociceptive sensitivity; Pain related proteins; Transgenic mice

Indexed keywords

ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR; BETA ENDORPHIN; BRADYKININ RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; ENKEPHALIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; NERVE GROWTH FACTOR; NEUROKININ; NEUROKININ A; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; NITRIC OXIDE; OPIATE; OPIATE RECEPTOR; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN E2; PROSTANOID; SEROTONIN RECEPTOR; SUBSTANCE P; TACHYKININ RECEPTOR; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG;

GENETIC ANALYSIS; HYPERALGESIA; KNOCKOUT MOUSE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0031670702     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00093-1     Document Type: Article

References (216)

1. Akil, H., Meng, F., Devine, D.P. and Watson, S.J., Molecular and neuroanatomical properties of the endogenous opioid system: implications for treatment of opiate addiction, Seminars Neurosci., 9 (1997) 70-83.
2. 1B receptor subtypes in modulating spinal nociceptive transmission in mice, J. Pharmacol. Exp. Ther., 265 (1993) 378-385.
3. Aloisi, A.M., Albonetti, M.E., Muscettola, M., Facchinetti, F., Tanganelli, C. and Carli, G., Effects of formalin-induced pain on ACTH, beta-endorphin, corticosterone and interleukin-6 plasma levels in rats, Neuroendocrinology, 62 (1995) 13-18.
4. Anand, P., Nerve growth factor regulates nociception in human health and disease, Br. J. Anaesth., 75 (1995) 201-208.
5. Baamonde, A.I., Dauge, V., Gacel, G. and Roques, B.P., Systemic administration of (Tyr-D-Ser(O-Tert-Butyl)-Gly-Phe-Leu-Thr(O-Tert-Butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice, J. Pharmacol. Exp. Ther., 257 (1991) 767-773.
6. Belknap, J.K. and Crabbe, J.C., Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice, Ann. N. Y. Acad. Sci., 654 (1992) 311-323.
7. Belknap, J.K., Laursen, S.E., Sampson, K.E. and Wilkie, A., Where are the mu receptors that mediate opioid analgesia? An autoradiographic study in the HAR and LAR selection lines, J. Addict. Dis., 10 (1991) 29-44.
8. Bentley, G.A., Newton, S.H. and Starr, J., Evidence for an action of morphine and the enkephalins on sensory nerve endings in the mouse peritoneum, Br. J. Pharmacol., 73 (1981) 325-332.
9. Bergmann, I., Priestley, J.V., McMahon, S.B., Brocker, E.B., Toyka, K.V. and Koltzenburg, M., Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75, Eur. J. Neurosci., 9 (1997) 18-28.
10. Besson, J.-M. and Chaouch, A., Peripheral and spinal mechanisms of nociception, Physiol. Rev., 67 (1987) 67-186.
11. Bianchi, M., Sacerdote, P., Poli, V. and Panerai, A.E., Interleukin-6 knock out mice exhibit increased hypothalamic beta-endorphin levels, and reduced opioid sensitivity, Soc. Neurosci. Abstr., 23 (1997) 678.
12. Birnbaumer, L., G proteins in signal transduction, Annu. Rev. Pharmacol. Toxicol., 30 (1990) 675-705.
13. 2-induced activation and sensitization of articular mechano-nociceptors, Neurosci. Lett., 125 (1991) 5-8.
14. Bollag, R.J., Waldman, A.S. and Liskay, R.M., Homologous recombination in mammalian cells, Annu. Rev. Genet., 23 (1989) 199-225.
15. Boschert, U., Amara, D.A., Segu, L. and Hen, R., The mouse 5-hydroxy-tryptamine IB receptor is localized predominantly on axon terminals, Neuroscience, 58 (1994) 167-182.
16. 2 bradykinin receptor knockout mice, Immunopharmacology, 33 (1996) 333-335.
17. Bradley, A., Evans, M., Kaufman, M.H. and Robertson, E.J., Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines, Nature, 309 (1984) 255-256.
18. Brocard, J., Warot, X., Wendling, O., Messaddeq, N., Vonesch, J.-L., Chambon, P. and Metzger, D., Spatio-temporally controlled site-specific somatic mutagenesis in the mouse, Proc. Natl. Acad. Sci. USA, 94 (1997) 14559-14563.
19. Bronson, S.K., Plaehn, E.G., Kluckman, K.D., Hagaman, J.R., Maeda, N. and Smithies, O., Single-copy transgenic mice with chosen-site integration, Proc. Natl. Acad. Sci. USA, 93 (1996) 9067-9072.
20. Bronson, S.K. and Smithies, O., Altering mice by homologous recombination using embryonic stem cells, J. Biol. Chem., 269 (1994) 27155-27158.
21. Buchsbaum, M.S., Davis, G.C. and Bunney, W.E. Jr., Naloxone alters pain perception and somatosensory evoked potentials in normal subjects, Nature, 270 (1977) 620-622.
22. Cadd, G.G. and McKnight, G.S., Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain, Neuron, 3 (1989) 71-79.
23. Cao, Y.Q., Mantyh, P.W., Carlson, E.J., Gillespie, A.-M., Epstein, C.J. and Basbaum, A.I., Primary afferent tachykinins are required to experience moderate to intense pain, Nature, 392 (1998) 390-394.
24. Capecchi, M.R., High efficiency transformation of DNA into cultured mammalian cells, Cell, 244 (1980) 1288-1292.
25. Cerne, R., Jiang, M.C. and Randic, M., Cyclic adenosine 3'5'-monophosphate potentiates excitatory amino acid and synaptic responses of rat spinal dorsal horn neurons, Brain Res., 596 (1992) 111-123.
26. Cesare, P. and McNaughton, P., Peripheral pain mechanisms, Curr. Opin. Neurobiol., 7 (1997) 493-499.
27. Chao, M.V., Neurotrophin receptors: a window into neuronal differentiation, Neuron, 9 (1992) 583-593.
28. Chung, K., Kim, H.J., Na, H.S., Park, M.J. and Chung, J.M., Abnormalities of sympathetic innervation in the area of an injured peripheral nerve in a rat model of neuropathic pain, Neurosci. Lett., 162 (1993) 85-88.
29. Coderre, T.J., Katz, J., Vaccarino, A.L. and Melzack, R., Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence, Pain, 52 (1993) 259-285.
30. 2 receptors in formalin-induced nociception in the mouse, Br. J. Pharmacol., 110 (1993) 193-198.
31. Costentin, J., Vlaiculescu, A., Chaillet, P., Ben-Natan, L., Aveaux, D. and Schwartz, J.C., Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses, Eur. J. Pharmacol., 123 (1986) 37-44.
32. Crawley, J.N., Unusual behavioral phenotypes of inbred mouse strains, Trends Neurol. Sci., 19 (1996) 181-182.
33. Crawley, J.N., Belknap, J.K., Coffins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A. an Paylor, R., Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies, Psychopharmacology, 132 (1997) 107-124.
34. Crosby, G., Marota, J.J.A. and Huang, P.L., Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase, Neuroscience, 69 (1995) 1013-1017.
35. Crowley, C., Spencer, S.D., Nishimura, M.C., Chen, K.S., Pitts-Meek, S., Armanini, M.P., Ling, L.H., McMahon, S.B., Shelton, D.L., Levinson, A.D. and Phillips, H.S., Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons, Cell, 76 (1994) 1001-1011.
36. Crusio, W.E., Gene-targeting studies: new methods, old problems, Trends Neurol. Sci., 19 (1996) 186-187.
37. Dahme, M., Bartsch, U., Martini, R., Anliker, B., Schachner, M. and Mantei, N., Disruption of the mouse L1 gene leads to malformations of the nervous system, Nature Genet., 17 (1997) 346-349.
38. Dallel, R., Raboisson, P., Clavelou, P., Saade, M. and Woda, A., Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin, Pain, 61 (1995) 11-16.
39. Davies, M.F., Kingery, W.S., Poree, L.R., Guo, T.Z. and Maze, M., The α2A adrenoceptor (α2A AR) is critical to the development of thermal, but not mechanical neuropathic hyperalgesia, Soc. Neurosci. Abstr., 23 (1997) 1538.
40. Davies, S.N. and Lodge, D., Evidence for involvement of N-methyl-D-aspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat, Brain Res., 424 (1987) 402-406.
41. 1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat, Neuropharmacology, 33 (1994) 127-133.
42. Davis, B.M., Albers, K.M., Seroogy, K.B. and Katz, D.M., Overexpression of nerve growth factor in transgenic mice induces novel sympathetic projections to primary sensory neurons, J. Comp. Neurol., 349 (1994) 464-474.
43. Davis, B.M., Lewin, G.R., Mendell, L.M., Jones, M.E. and Albers, K.M., Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli, Neuroscience, 56 (1993) 789-792.
44. Dawson, T.M. and Snyder, S.H., Gases as biological messengers: nitric oxide and carbon monoxide in the brain, J. Neurosci., 14 (1994) 5147-5159.
45. de Castro, F., Silos-Santiago, I., de Armentia, M.L., Barbacid, M. and Belmonte, C., Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice, Eur. J. Neurosci., 10 (1998) 146-152.
46. De Felipe, C., Herrero, J.F., O'Brien, J.A., Palmer, J.A., Doyle, C.A., Smith, A.J.H., Laird, J.M.A., Belmonte, C., Cervero, F. and Hunt, S.P., Altered nociception, analgesia and aggression in mice lacking the receptor for substance P, Nature, 392 (1998) 394-397.
47. De Lander, G.E. and Keil, G.J. Jr., Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice, J. Pharmacol. Exp. Ther., 268 (1994) 943-951.
48. DeBiasi, S. and Rustioni, A., Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord, Proc. Natl. Acad. Sci. USA, 85 (1988) 7820-7824.
49. Dickenson, A.H., Spinal cord pharmacology of pain, Br. J. Anaesth., 75 (1995) 193-200.
50. Dickenson, A.H. and Sullivan, A.F., Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep dorsal horn nociceptive neurones following C fibre stimulation, Neuropharmacology, 26 (1987) 1235-1238.
51. Donovick, P.J., Burright, R.G., Fanelli, R.J. and Engellenner, W.J., Septal lesions and avoidance behavior: genetic, neurochemical and behavioral considerations, Physiol. Behav., 26 (1981) 495-507.
52. Dores, R.M., Akil, H. and Watson, S.J., Strategies for studying opioid peptide regulation at the gene, message and protein levels, Peptides, 5 (Suppl. 1 )(1984) 9-17.
53. Dray, A., Inflammatory mediators of pain, Br. J. Anaesth., 75 (1995) 125-131.
54. Dray, A. and Perkins, M., Bradykinin and inflammatory pain, Trends Neurosci., 16 (1993) 99-104.
55. El-Sobky, A., Dostrovsky, J.O. and Wall, P.D., Lack of effect of naloxone on pain perception in humans, Nature, 263 (1976) 783-784.
56. 2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade, J. Physiol., 495 (1996) 429-440.
57. Eriksson, N.P., Lindsay, R.M. and Aldskogius, H., BDNF and NT-3 rescue sensory but not motor neurons following axotomy in the neonate, Neuroreport, 5 (1994) 1445-1448.
58. Fang, F.G., Fields, H.L. and Lee, N.M., Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates, J. Pharmacol. Exp. Ther., 238 (1986) 1039-1044.
59. Farrar, M.A. and Schreiber, R.D., The molecular cell biology of interferon-gamma and its receptor, Annu. Rev. Immunol., 11 (1993) 571-611.
60. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P. and Poli, V., Defective inflammatory response in interleukin 6-deficient mice, J. Exp. Med., 180 (1994) 1243-1250.
61. Ferreira, S.H., Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics, Trends Pharmacol. Sci., 2 (1981) 183-186.
62. Festing, M.F.W., From character to gene: some strategies for identifying single genes controlling behavioral characters. In: D. Goldowitz, D. Wahlsten and R.E. Wimer (Eds.), Techniques for the Genetic Analysis of Brain and Behavior, Elsevier, Amsterdam, 1992, pp. 17-38.
63. Fleetwood-Walker, S.M., Parker, R.M.C., Munro, F.E., Young, M.R., Hope, R.J. and Mitchell, R., Evidence for a role of tachykinin NK(2)-receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons, Eur. J. Pharmacol., 242 (1993) 173-181.
64. Funada, M., Sora, I., Goodman, N., Li, X., Kinsey, S. and Uhl, G.R., DPDPE and U50,488 in μ receptor knockout mice: evidence for μ-dependent κ and δ effects on analgesia, tolerance and/or dependence, Soc. Neurosci. Abstr., 23 (1997) 584.
65. Furth, P.A., St. Onge, L., Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H. and Hennighausen, L., Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter, Proc. Natl. Acad. Sci. USA, 91 (1994) 9302-9306.
66. Gerlai, R., Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?, Trends Neurol. Sci., 19 (1996) 177-181.
67. Glennon, R.A. and Dukat, M., Serotonin receptors and their ligands: a lack of selective agents, Pharmacol. Biochem. Behav., 40 (1991) 1009-1017.
68. + current in nociceptors, Proc. Natl. Acad. Sci. USA, 93 (1996) 1108-1112.
69. Good, M., Targeted deletion of neuronal nitric oxide: a step closer to understanding its functional significance?, Trends Neurosci., 19 (1996) 83-84.
70. Goto, T., Marota, J.J.A. and Crosby, G., Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane, Anesthesiology, 80 (1994) 409-416.
71. Grisel, J.E., Mogil, J.S., Belknap, J.K. and Grandy, D.K., Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide, Neuroreport, 7 (1996) 2125-2129.
72. Grisel, J.E., Mogil, J.S., Belknap, J.K. and Low, MJ., β-Endorphin knockout mice display altered analgesic responses to centrally-administered opioid agonists, Soc. Neurosci. Abstr., 23 (1997) 678.
73. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. and Rajewsky, K., Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting, Science, 265 (1994) 103-106.
74. Hargreaves, K., Dubner, R., Brown, F., Flores, C. and Joris, J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32 (1988) 77-88.
75. Hasty, P., Ramirez-Solis, R., Krumlauf, R. and Bradley, A., Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells, Nature, 350 (1991) 243-246.
76. Hayashi, Y. and Maze, M., Alpha 2 adrenoceptor agonists and anaesthesia, Br. J. Anesthesiol., 71 (1993) 108-118.
77. Heapy, C.G., Shaw, J.S. and Farmer, S.C., Differential sensitivity of antinociception assays to the bradykinin antagonist HOE140, Br. J. Pharmacol., 108 (1993) 209-213.
78. Henderson, G. and McKnight, A.T., The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ, Trends Pharmacol. Sci., 18 (1997) 293-300.
79. Hieble, J.P. and Ruffolo, R.R. Jr., Subclassification and nomenclature of alpha 1- and alpha 2-adrenoceptors, Prog. Drug Res., 47 (1996) 81-130.
80. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. and Humphrey, P.P., International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin), Pharmacol. Rev., 46 (1994) 157-203.
81. Hug, H. and Sarre, T.F., Protein kinase C isoenzymes: divergence in signal transduction?, Biochem. J., 291 (1993) 329-343.
82. 2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermie action of dexmedetomidine in transgenic mice, Br. J. Pharmacol., 122 (1997) 1339-1344.
83. Hylden, J.L.K. and Wilcox, G.L., Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice, Brain Res., 217 (1981) 212-215.
84. Indo, Y., Tsurata, Y., Karim, M.A., Ohta, K., Kawano, T., Mitsubuchi, H., Tonoki, H., Awaya, Y. and Matsuda, I., Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis, Nature Genet., 13 (1996) 485-488.
85. o, Proc. Natl. Acad. Sci. USA, 95 (1998) 3269-3274.
86. Jiang, Q., Mosberg, H.I. and Porreca, F., Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse, J. Pharmacol. Exp. Ther., 254 (1990) 683-689.
87. Kaufmann, S.H., Bacterial and protozoal infections in genetically disrupted mice, Curr. Opin. Immunol., 6 (1994) 518-525.
88. Kelly, M.A., Rubinstein, M., Phillips, T.J., Lessov, C.N., Burkhart-Kasch, S., Zhang, G., Bunzow, J.R., Fang, Y., Gerhardt, G.A., Grandy, D.K. and Low, M.J., Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations, J. Neurosci., 18 (1998) 3470-3479.
89. Khawaja, A.M. and Rogers, D.F., Tachykinins: receptor to effector, Int. J. Biochem. Cell. Biol., 28 (1996) 721-738.
90. Kieffer, B.L., Matthes, H.W.D., Peluso, J. and Gaveriaux-Ruff, C., Study of immune response in mu-opioid receptor (MOR) deficient mice, Soc. Neurosci. Abstr., 23 (1997) 584.
91. Kirchgessner, A.L., Bodnar, R.J. and Pasternak, G.W., Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model, Pharmacol. Biochem. Behav., 17 (1982) 1175-1179.
92. Kolesnikov, Y., Jain, S., Wilson, R. and Pasternak, G.W., Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for an NMDA receptor defect, J. Pharmacol. Exp. Ther., 284 (1998) 455-459.
93. Konig, M., Zimmer, A.M., Steiner, H., Holmes, P.V., Crawley, J.N., Brownstein, M.J. and Zimmer, A., Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin, Nature, 383 (1996) 535-538.
94. Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K., Inducible gene targeting in mice, Science, 269 (1995) 1427-1429.
95. 2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo, Proc. Natl. Acad. Sci. USA, 94 (1997) 9950-9955.
96. Lathe, R., Mice, gene targeting and behaviour: more than just genetic background, Trends Neurol. Sci., 19 (1996) 183-186.
97. 2a receptor, Nature, 388 (1997) 674-678.
98. Lee, K.-F., Li, E., Huber, J., Landis, S.C., Sharpe, A.H., Chao, M.V. and Jaenisch, R., Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system, Cell, 69 (1992) 737-749.
99. Lembeck, F., Folkers, K. and Donnerer, J., Analgesic effects of antagonists of substance P, Biochem. Biophys. Res. Commun., 103 (1981) 1318-1321.
100. Leslie, T.A., Emson, P.C., Dowd, P.M. and Woolf, C.J., Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation, J. Neurosci., 67 (1995) 753-761.
101. Levi-Montalcini, R., The nerve growth factor: thirty five years later, EMBO J., 6 (1987) 1145-1154.
102. Levine, J.D., Fields, H.L. and Basbaum, A.I., Peptides and the primary afferent nociceptor, J. Neurosci., 13 (1993) 2273-2286.
103. Levine, J.D., Gordon, N.C. and Fields, H.L., Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain, Nature, 278 (1979) 740-741.
104. Lewin, G.R. and Mendell, L.M., Nerve growth factor and nociception, Trends Neurol. Sci., 16 (1993) 353-359.
105. Lin, Q., Peng, Y.B. and Willis, W.D., Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons, J. Neurosci., 16 (1996) 3026-3034.
106. Lindsay, R.M. and Harmar, A.J., Nerve growth factor regulates expression in neuropeptide genes in adult sensory neurones, Nature, 337 (1989) 362-364.
107. 2a-adrenergic receptor subtype, Science, 273 (1996) 801-803.
108. Malmberg, A.B., Brandon, E.P., Idzerda, R.L., Liu, H., McKnight, G.S. and Basbaum, A.I., Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the Type I regulatory subunit of cAMP-dependent protein kinase, J. Neurosci., 17 (1997a) 7462-7470.
109. Malmberg, A.B., Chen, C., Tonegawa, S. and Basbaum, A.I., Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ, Science, 278 (1997b) 279-283.
110. Malmberg, A.B., Hedley, L., Jasper, J.R., Hunter, J.C. and Basbaum, A.I., Neuropathic pain behavior develops in mice that lack alpha 2A, 2B or 2C adrenergic receptors (ARs) but its regulation by dexmedetomidine requires the 2A receptor, Soc. Neurosci. Abstr., 23 (1997c) 1538.
111. Mamiya, T., Noda, Y., Nishi, M., Takeshima, H. and Nabeshima, T., Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice, Brain Res., 783 (1998) 236-240.
112. Mansour, S.L., Thomas, K.R. and Capecchi, M.R., Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes, Nature, 336 (1988) 348-352.
113. 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy, J. Neurophysiol., 70 (1993) 70-81.
114. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., Tzavara, E., Hanoune, J., Roques, B.P. and Kieffer, B.L., Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene, Nature, 383 (1996) 819-823.
115. Matthes, H.W.D., Maldonado, R., Smadia, C., Valverde, O., Roques, B. and Kieffer, B.L., Functional response of delta- and kappa-opioid receptors in mu-opioid receptor knock-out mice, Soc. Neurosci. Abstr., 23 (1997) 583.
116. Mayford, M., Bach, M.E., Huang, Y.-Y., Wang, L., Hawkins, R.D. and Kandel, E.R., Control of memory formation through regulated expression of a CaMKII transgene, Science, 274 (1997) 1678-1683.
117. 3 type tachykinin receptor mRNA expression in rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception, J. Neurosci., 14 (1994) 712-720.
118. McLeod, A.L., Ritchie, J., Cuello, A.C., Julien, J.-P., Ribeiro-da-Silva, A. and Henry, J.L., Transgenic mice over-expressing nerve growth factor exhibit thermal allodynia and hyperalgesia which are reversed by substance P and NMDA receptor antagonists, Soc. Neurosci. Abstr., 23 (1997) 1806.
119. McMahon, S.B. and Priestley, J.V., Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives, Curr. Opin. Neurobiol., 5 (1995) 616-624.
120. Meller, S.T., Thermal and mechanical hyperalgesia: a distinct role for different excitatory amino acid receptors and signal transduction pathways?, APS J., 3 (1994) 215-231.
121. Meller, S.T. and Gebhart, G.F., Nitric oxide and nociceptive processing in the spinal cord, Pain, 52 (1993) 127-136.
122. 1 receptor, Nature, 377 (1995) 532-535.
123. Millan, M.J., Multiple opioid systems and pain, Pain, 27 (1986) 303-347.
124. Millan, M.J. and Colpaert, F.C., α2 Receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice, Brain Res., 539 (1991) 342-346.
125. Mogil, J.S., Grisel, J.E., Reinscheid, R.K., Civelli, O., Belknap, J.K. and Grandy, D.K., Orphanin FQ is a functional anti-opioid peptide, Neuroscience, 75 (1996a) 333-337.
126. Mogil, J.S., Grisel, J.E., Zhang, G., Belknap, J.K. and Grandy, D.K., Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ, Neurosci. Lett., 214 (1996b) 131-134.
127. Mogil, J.S., Lichtensteiger, C.A. and Wilson, S.G., The effect of genotype on sensitivity to inflammatory nociception: characterization of resistant (A/J) and sensitive (C57BL/6) inbred mouse strains, Pain, 76 (1998) 115-125.
128. Mogil, J.S., Sadowski, B. and Belknap, J.K., The role of the serotonin-1B receptor in genetic sensitivity to opiate analgesia in mice, Soc. Neurosci. Abstr., 21 (1995) 1415.
129. Mogil, J.S., Sternberg, W.F., Balian, H., Liebeskind, J.C. and Sadowski, B., Opioid and non-opioid swim stress-induced analgesia: a parametric analysis in mice, Physiol. Behav., 59 (1996c) 123-132.
130. Mogil, J.S. and Wilson, S.G., Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies, Eur. J. Pain, 1 (1997) 293-297.
131. Morris, R. and Nosten-Bertrand, M., NOS and aggression, Trends Neurosci., 19 (1996) 277-278.
132. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S. and Narumiya, S., Altered pain perception and inflammatory response in mice lacking prostacyclin receptor, Nature, 388 (1997) 678-682.
133. 1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes, Psychopharmacology, 108 (1992) 123-130.
134. 1A/1B agonists differentially affect spinal nociceptive reflexes, Neuropharmacology, 29 (1990) 463-468.
135. Neumann, S., Doubell, T.P., Leslie, T. and Woolf, C.J., Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons, Nature, 384 (1996) 360-364.
136. Nishi, M., Houtani, T., Noda, Y., Mamiya, T., Sato, K., Doi, T., Kuno, J., Takeshima, H., Nukada, T., Nabeshima, T., Yamashita, T., Noda, T. and Sugimoto, T., Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor, EMBO J., 16 (1997) 1858-1864.
137. Ohkubo, T., Shibata, M., Takahashi, H. and Inoki, R., Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord, J. Pharmacol. Exp. Ther., 252 (1990) 1261-1268.
138. Parenti, M., Tirone, F., Giagnoni, G., Pecora, N. and Parolaro, D., Pertussis toxin inhibits the antinociceptive action of morphine in the rat, Eur. J. Pharmacol., 124 (1986) 357-359.
139. Pasternak, G.W., Pharmacological mechanisms of opioid analgesics, Clin. Neuropharmacol., 16 (1993) 1-18.
140. Paterson, S.J., Robson, L.E. and Kosterlitz, H.W., Classification of opioid receptors, Br. Med. Bull., 39 (1983) 31-36.
141. Patil, N., Lacy, E. and Chao, M.V., Specific neuronal expression of human NGF receptors in the basal forebrain and cerebellum of transgenic mice, Neuron, 2 (1990) 437-447.
142. Piccioli, P., Di Luzio, A., Amann, R., Schuligoi, R., Surani, M.A., Donnerer, J. and Cattaneo, A., Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice, Neuron, 15 (1995) 373-384.
143. 3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice, Neuroreport, 7 (1995) 353-359.
144. Porreca, F. and Burks, T.F., Supraspinal opioid receptors in antinociception. In: A. Herz (Ed.), Opioids II: Handbook in Experimental Pharmacology, Springer-Verlag, New York, 1993, pp. 21-51.
145. Porro, C.A. and Cavazzuti, M., Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model, Prog. Neurobiol., 41 (1993) 565-607.
146. Przewlocki, R., Costa, T., Lang, J. and Herz, A., Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord, Eur. J. Pharmacol., 144 (1987) 91-95.
147. Puig, S. and Sorkin, L.S., Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity, Pain, 64 (1995) 345-355.
148. Regoli, D. and Barabe, J., Pharmacology of bradykinin and related kinins, Pharmacol. Rev., 32 (1980) 1-46.
149. Reinscheid, R.K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. and Civelli, O., Orphanin FQ: a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor, Science, 270 (1995) 792-794.
150. Richardson, B.P., Serotonin and nociception, Ann. N. Y. Acad. Sci., 600 (1990) 511-520.
151. Robertson, B., Xu, X.-J., Hao, J.-X., Wiesenfeld-Hallin, Z., Mhlanga, J., Grant, G. and Kristensson, K., Interferon-γ receptors in nociceptive pathways: role in neuropathic pain-related behavior, Neuroreport, 8 (1997) 1311-1316.
152. Roques, B.P., Noble, F., Dauge, V., Fournie-Zaluski, M.C. and Beaumont, A., Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology, Pharmacol. Rev., 45 (1993) 87-146.
153. Rossi, G.C., Brown, G.P., Leventhal, L., Yang, K. and Pasternak, G.W., Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia, Neurosci. Lett., 216 (1996a) 1-4.
154. Rossi, G.C., Leventhal, L., Bolan, E.A. and Pasternak, G.W., Pharmacological characterization of orphanin FQ/nociceptin and its fragments, J. Pharmacol. Exp. Ther., 282 (1997a) 858-865.
155. Rossi, G.C., Leventhal, L., Pan, Y.-X., Cole, J., Su, W., Bodnar, R.J. and Pasternak, G.W., Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception, J. Pharmacol. Exp. Ther., 281 (1997b) 109-114.
156. Rossi, G.C., Leventhal, L. and Pasternak, G.W., Naloxone sensitive orphanin FQ-induced analgesia in mice, Eur. J. Pharmacol., 311 (1996b) R7-8.
157. Rothman, R.B., A review of the role of anti-opioid peptides in morphine tolerance and dependence, Synapse, 12 (1992) 129-138.
158. Rothman, R.B. and Westfall, T.C., Allosteric coupling between morphine and enkephalin receptors in vitro, Mol. Pharmacol., 21 (1982) 548-557.
159. Routtenberg, A., Reverse piedpiperase: is the knockout mouse leading neuroscientists to a watery end?, Trends Neurol. Sci., 19 (1996) 471-472.
160. Rozmahel, R., Wilschanski, M., Matin, A., Plyte, S., Oliver, M., Auerbach, W., Moore, A., Forstner, J., Durie, P., Nadeau, J., Bear, C. and Tsui, L.C., Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor, Nature Genet., 12 (1996) 280-287.
161. Rubinstein, M., Japon, M. and Low, M.J., Introduction of a point mutation into the mouse genome by homologous recombination in embryonic stem cells using a replacement type vector with a selectable marker, Nuc. Acids Res., 21 (1993) 2613-2617.
162. Rubinstein, M., Mogil, J.S., Japon, M., Chan, E.C., Allen, R.G. and Low, M.J., Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis, Proc. Natl. Acad. Sci. USA, 93 (1996) 3995-4000.
163. 2 receptor on nociception in rats and mice, Pain, 71 (1997) 89-97.
164. Sanchez-Blazquez, P., Garcia-Espana, A. and Garzon, J., In vivo injection of antisense oligodeoxynucleotides to Ga subunits and supraspinal analgesia evoked by mu and delta opioid agonists, J. Pharmacol. Exp. Ther., 275 (1995) 1590-1596.
165. Saria, A., Hauser, K.F., Traurig, H., Turbek, C.S., Hersh, L. and Gerard, C., Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice, Neurosci. Lett., 234 (1997) 27-30.
166. 1B receptor, Science, 265 (1994) 1875-1878.
167. Sawynok, J. and Sweeney, M.I., The role of purines in nociception, Neuroscience, 32 (1989) 557-569.
168. Schauwecker, P.E. and Steward, O., Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches, Proc. Natl. Acad. Sci., USA, 94 (1997) 4103-4108.
169. 1B receptor agonist with antinociceptive/antidepressant-like actions in rodents, Br. J. Pharmacol., 105 (1992) 732-738.
170. Schuller, A.G.P., King, M., Zhang, J., Czick, M., Unterwald, E., Pasternak, G.W. and Pintar, J.E., Heroin and M6G analgesia are retained in mu opioid receptor deficient mice, Soc. Neurosci. Abstr., 23 (1997) 548.
171. Seltzer, Z., Dubner, R. and Shir, Y., A novel behavioral model of causalgiform pain produced by partial sciatic nerve injury in rats, Pain, 43 (1990) 205-218.
172. Shastry, B.S., More to learn from gene knockouts, Mol. Cell. Biochem., 136 (1994) 171-182.
173. Sibilia, M. and Wagner, E.F., Strain-dependent epithelial defects in mice lacking the EGF receptor, Science, 269 (1995) 234-238.
174. Sigmund, C.D., Major approaches for generating and analyzing transgenic mice, An overview, Hypertension, 22 (1993) 599-607.
175. Silva, A.J., Paylor, R., Wehner, J.M. and Tonegawa, S., Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice, Science, 257 (1992a) 206-211.
176. Silva, A.J., Stevens, C.F., Tonegawa, S. and Wang, Y., Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant
177. Simon, E.J., Opioid receptors and endogenous opioid peptides, Med. Res. Rev., 11 (1991) 357-374.
178. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B.P., Maldonado, R. and Kieffer, B.L., Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal, EMBO J., 17 (1998) 886-897.
179. Simpson, E.M., Linder, C.C., Sargent, E.E., Davisson, M.T., Mobraaten, L.E. and Sharp, J.J., Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice, Nature Genet., 16 (1997) 19-27.
180. Siuciak, J.A., Altar, C.A., Wiegand, S.J. and Lindsay, R.M., Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3, Brain Res., 633 (1994) 326-330.
181. Smeyne, R.J., Klein, R., Schnapp, A., Long, L.K., Bryant, S., Lewin, A., Lira, S.A. and Barbacid, M., Severe sensory neuropathies in mice carrying a disrupted Trk/NGF receptor gene, Nature, 368 (1994) 246-249.
182. Smithies, O., Gregg, R.G., Boggs, S.S., Koralewski, M.A. and Kucherlapati, R.S., Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination, Nature, 317 (1985) 230-234.
183. Smithies, O. and Kim, H.S., Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice, Proc. Natl. Acad. Sci. USA, 91 (1994) 3612-3615.
184. Snyder, S.H., Nitric oxide: first in a new class of neurotransmitters, Science, 257 (1992) 494-496.
185. 5]enkephalin-induced analgesia, Eur. J. Pharmacol., 324 (1997a) R1-R3.
186. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R.S., Donovan, D.M., Miner, L.L. and Uhl, G.R., Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia, Proc. Natl. Acad. Sci., USA, 94 (1997b) 1544-1549.
187. Standifer, K.M., Rossi, G. and Pasternak, G.W., Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits, J. Pharmacol. Exp. Ther., 50 (1996) 293-298.
188. 2 agonists and is necessary for spinal adrenergic-opioid synergy, J. Neurosci., 17 (1997) 7157-7165.
189. Sutters, K.A., Miaskowski, C., Taiwo, Y.O. and Levine, J.D., Analgesic synergy and improved motor function produced by combinations of μ-δ and μ-κ-opioids, Brain Res., 530 (1990) 290-294.
190. Taiwo, Y.O., Bjerknes, L.K., Goetzl, E.J. and Levine, J.D., Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system, Neuroscience, 32 (1989) 577-580.
191. Taiwo, Y.O. and Levine, J.D., Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia, Brain Res., 458 (1988) 402-406.
192. Taylor, B.K., Peterson, M.A. and Basbaum, A.I., Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input, J. Neurosci., 15 (1995) 7575-7584.
193. Threadgill, D.W., Dlugosz, A.A., Hansen, L.A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R.C., Barnard, J.A., Yuspa, S.H., Coffey, R.J. and Magnuson, T., Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype, Science, 269 (1995) 230-233.
194. Threadgill, D.W., Yee, D., Matin, A., Nadeau, J.H. and Magnuson, T., Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain, Mamm., Genome, 8 (1997) 390-393.
195. Tian, M., Broxmeyer, H.E., Fan, Y., Lai, Z., Zhang, S., Aronica, S., Cooper, S., Bigsby, R.M., Steinmetz, R., Engle, S.J., Mestek, A., Pollock, J.D., Lehman, M.N., Jansen, H.T., Ying, M., Stambrook, P.J., Tischfield, J.A. and Yu, L., Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice, J. Exp. Med., 185 (1997) 1517-1522.
196. Tjolsen, A., Berge, O.-G., Hunskaar, S., Rosland, J.H. and Hole, K., The formalin test: an evaluation of the method, Pain, 51 (1992) 5-17.
197. Treede, R.-D., Meyer, R.A., Raja, S.N. and Campbell, J.N., Peripheral and central mechanisms of cutaneous hyperalgesia, Prog. Neurobiol., 38 (1992) 397-421.
198. Ueda, H., Nozaki, M. and Satoh, M., Multiple opioid receptors and GTP-binding proteins, Comp. Biochem. Physiol., 98C (1991) 157-169.
199. Ueda, H., Yamaguchi, T., Tokuyama, S., Inoue, M., Nishi, M. and Takeshima, H., Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene, Neurosci. Lett., 237 (1997) 136-138.
200. Uhl, G.R., Funada, M., Revay, R., Takahashi, N., Ujike, H. and Sora, I., μ Receptor knockout mice: gene dose effects on morphine actions and evidence for differential in vivo μ receptor reserve, Soc. Neurosci. Abstr., 23 (1997) 583.
201. Ushikubi, F., Hirata, M. and Narumiya, S., Molecular biology of prostanoid receptors: an overview, J. Lip. Mediat., 12 (1995) 343-359.
202. 2 mediates inflammatory hyperemia, Nature, 293 (1981) 583-585.
203. Whittington, M.A., Sidle, K.C., Gowland, T., Meads, J., Hill, A.F., Palmer, M.S., Jeffreys, J.G. and Collinge, J., Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein, Nature Genet., 9 (1995) 197-201.
204. Williams, K.M., Day, R.O. and Breit, S.N., Biochemical actions and clinical pharmacology of anti-inflammatory drugs, Adv. Drug Res., 24 (1993) 121-198.
205. Wood, J.N., No pain, some gain, Nature Genet., 13 (1996) 382-383.
206. Woolf, C.J., Somatic pain - pathogenesis and prevention, Br. J. Anaesth., 75 (1995) 169-176.
207. Woolf, C.J. and Thompson, S.W.N., The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states, Pain, 44 (1991) 293-299.
208. Xu, W., Qiu, X.C. and Han, J.S., Serotonin receptor subtypes in spinal antinociception in the rat, J. Pharmacol. Exp. Ther., 269 (1994a) 1182-1188.
209. Xu, X.-J., Hao, J.X., Olsson, T., Kristensson, K., van der Meide, P.H. and Wiesenfeld-Hallin, Z., Intrathecal interferon-gamma facilitates the spinal nociceptive flexor reflex in the rat, Neurosci. Lett., 182 (1994b) 263-266.
210. Xu, X.-J., Hao, J.-X., Andell-Jonsson, S., Poli, V., Bartfai, T. and Wiesenfeld-Hallin, Z., Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section, Cytokine, 9 (1997) 1028-1033.
211. Yaksh, T.L., Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing, Pharmacol. Biochem. Behav., 22 (1985) 845-858.
212. Yamada, K. and Nabeshima, T., Stress-induced behavioral responses and multiple opioid systems in the brain, Behav. Brain Res., 67 (1995) 133-145.
213. Zhu, Y., King, M., Schuller, A., Unterwald, E., Pasternak, G. and Pintar, J.E., Genetic disruption of the mouse delta opioid receptor gene, Soc. Neurosci. Abstr., 23 (1997) 584.
214. Zimmer, A., Manipulating the genome by homologous recombination in embryonic stem cells, Annu. Rev. Neurosci., 15 (1992) 115-137.
215. Zimmer, A., Gene targeting and behaviour: a genetic problem requires a genetic solution, Trends Neurol. Sci., 19 (1996) 470-471.
216. Zimmer, A., Zimmer, A.M., Baffi, J., Usdin, T., Reynolds, K., Konig, M., Palkovits, M. and Mezey, E., Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene, Proc. Natl. Acad. Sci. USA, 95 (1998) 2630-2635.